• 1
    Coory M, Baade PD, Aitken JF, Smithers M, McLeod GRC, Ring I. Trends for in-situ and invasive melanoma in Queensland, Australia, 1982 to 2002. Cancer Causes and Control 2006; 17: 217.
  • 2
    Jemal A, Devesa SS, Hartge P, Tucker MA. Recent Trends in Cutaneous Melanoma Incidence Among Whites in the United States. J Natl Cancer Inst 2001; 93: 67883.
  • 3
    Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007; 82: 36480.
  • 4
    Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A, Jr., Kirkwood JM, McMasters KM, Mihm MF, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004; 54: 13149.
  • 5
    Coory M, Smithers M, Aitken J, Baade P, Ring I. Urban-rural differences in survival from cutaneous melanoma in Queensland. Aust N Z J Public Health 2006; 30: 714.
  • 6
    Youlden D, Baade PD, Coory MD. Cancer Survival in Queensland 2002. Queensland Health and Queensland Cancer Fund. Available at: Accessed August 10, 2007.
  • 7
    Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89: 126978.
  • 8
    Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. Journal of the National Cancer Institute 1996; 88: 1723.
  • 9
    McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. Journal of the American Academy of Dermatology 2006; 54: 78392.
  • 10
    US Preventive Services Task Force. Screening for skin cancer: recommendations and rationale. Am J Prev Med 2001; 20: 446.
  • 11
    The Cancer Council Australia, National Cancer Prevention Policy 2007-09. The Cancer Council Australia. Available at: Accessed: Nov 27, 2007.
  • 12
    QCF, Queensland Cancer Risk Study Results. Viertel Centre for Research in Cancer Control, Queensland Cancer Fund. 2005Available at: Accessed: Sept. 19, 2007).
  • 13
    Aitken JF, Janda M, Lowe JB, Elwood M, Ring IT, Youl PH, Firman DW. Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia). Cancer Causes Control 2004; 15: 45363.
  • 14
    Youl PH, Baade PD, English DR, Elwood JM, Aitken JF. Clinical skin examinations and the increasing role of primary care skin cancer clinics in Queensland, Australia. In submission.
  • 15
    Burton RC, Armstrong BK. Current melanoma epidemic: a nonmetastasizing form of melanoma? World J. Surg. 1995; 19: 3303.
  • 16
    Rees JL. The melanoma epidemic: reality and artefact. BMJ 1996; 312: 1378.
  • 17
    Swerlick RA, Chen S. The melanoma epidemic: is increased surveillance the solution or the problem. Archives of Dermatology 1996; 132: 8814.
  • 18
    Aitken JF, Elwood JM, Lowe JB, Firman DW, Balanda KP, Ring I. A randomised trial of population screening for melanoma. J. Med. Screen. 2002; 9: 337.
  • 19
    Aitken JF, Youl PH, Janda M, Elwood M, Ring IT, Lowe JB, Firman DW. Validity of self-reported skin screening histories. Am J Epidemiol 2004; 159: 1098105.
  • 20
    English DR, Armstrong BK. Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. Br. Med. J. (Clin. Res. Ed). 1988; 296: 12858.
  • 21
    MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989; 2: 48790.
  • 22
    AIHW, Rural, regional and remote health: A guide to remoteness classifications. Australian Institute of Health and Welfare AIHW Cat. No. PHE 53, 2004.
  • 23
    Cohen J. A Coefficient of Agreement for Nominal Scales. Educational and Psychological Measurement 1960; 20: 3746.
  • 24
    Breslow A. Problems in the measurement of tumor thickness and level of invasion in cutaneous melanoma. Hum. Pathol. 1977; 8: 12.
  • 25
    Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg. 1970; 172: 9028.
  • 26
    Weinberg CR. Toward a clearer definition of confounding. Am J Epidemiol 1993; 137: 18.
  • 27
    Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A, Jr., Kirkwood JM, McMasters KM, Mihm MF, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 363548.
  • 28
    SAS Institute Inc. SAS OnlineDoc®, Version 9.1.2 Cary, NC: SAS Institute Inc, 2004.
  • 29
    Weiss N, Lazovich D. Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavourable outcome. Am J Epidemiol 1996; 143: 31922.
  • 30
    Youl PH, Baade P, Janda M, Whiteman DC, Del Mar CB, Aitken JF. Diagnosing skin cancer in primary care: how do mainstream GPs compare with primary care skin cancer clinic doctors? Medical Journal of Australia 2007; 187: 21520.